Exact Mass: 446.15836060000004
Exact Mass Matches: 446.15836060000004
Found 185 metabolites which its exact mass value is equals to given mass value 446.15836060000004
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Osmanthuside A
Osmanthuside C is found in herbs and spices. Osmanthuside C is isolated from Osmanthus fragrans (sweet osmanthus). Isolated from Osmanthus fragrans (sweet osmanthus). Osmanthuside C is found in herbs and spices.
Gefitinib
C22H24ClFN4O3 (446.15208759999996)
Gefitinib (originally coded ZD1839) is a drug used in the treatment of certain types of cancer. Acting in a similar manner to erlotinib (marketed as Tarceva), gefitinib selectively targets the mutant proteins in malignant cells. It is marketed by AstraZeneca under the trade name Iressa. [Wikipedia] L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents
2H-1-Benzopyran-3,4-diol, 2-(3,4-dimethoxyphenyl)-3,4-dihydro-7,8-dimethoxy-, diacetate, [2R-(2.alpha.,3.alpha.,4.alpha.)]-
(2S,4R)-7,4-dihydroxy-6,8-dimethyl-4,2-oxidoflavan-5-O-beta-D-glucopyranoside|abacopterin F
nepodin-8-O-beta-D-(60-O-trans-crotonoyl)glucopyranoside|rumexneposide A
7-O-beta-glucopyranosyl demethoxymatteucinol|demethoxymatteucinol-7-O-beta-D-glucopyranoside|demethoxymatteuocinol 7-O-glucopyranoside
5,6,6-Trimethoxy-4,10-dihydroxy-11,12-dimethyl-4,5-(epoxymethanoxy)-2,2-butanobiphenyl-3-carboxylic acid
7-beta-D-glucopyranosyloxymethyl-9-methoxy-5H-dibenzo[a,c][7]annulene-3,10-diol|subavenoside C
(-)-15-methoxypodorhizol|(-)-5-methoxypodorhizol|5-Methoxypodorhizol
(1R,2R)-1-(3-methoxy-4,5-methylenedioxyphenyl)-2-methyl-3-oxobutyl 3,4,5-trimethoxybenzoate|tsangin B
O-beta-D-Galactopyranosyl-(1->4)-O-beta-D-galactopyranosyl-(1->2)-L-erythritol
(1S,2R)-2-methyl-3-oxo-1-(3,4,5-trimethoxyphenyl)butyl 3-methoxy-4,5-methylenedioxybenzoate|tsangin A
Cys His Ser Thr
C16H26N6O7S (446.15836060000004)
Cys His Thr Ser
C16H26N6O7S (446.15836060000004)
Cys Met Pro Pro
Cys Asn Asn Pro
C16H26N6O7S (446.15836060000004)
Cys Asn Pro Asn
C16H26N6O7S (446.15836060000004)
Cys Pro Met Pro
Cys Pro Asn Asn
C16H26N6O7S (446.15836060000004)
Cys Pro Pro Met
Cys Ser His Thr
C16H26N6O7S (446.15836060000004)
Cys Ser Thr His
C16H26N6O7S (446.15836060000004)
Cys Thr His Ser
C16H26N6O7S (446.15836060000004)
Cys Thr Ser His
C16H26N6O7S (446.15836060000004)
Asp Asp Pro Thr
C17H26N4O10 (446.16488560000005)
Asp Asp Thr Pro
C17H26N4O10 (446.16488560000005)
Asp Glu Pro Ser
C17H26N4O10 (446.16488560000005)
Asp Glu Ser Pro
C17H26N4O10 (446.16488560000005)
Asp Pro Asp Thr
C17H26N4O10 (446.16488560000005)
Asp Pro Glu Ser
C17H26N4O10 (446.16488560000005)
Asp Pro Ser Glu
C17H26N4O10 (446.16488560000005)
Asp Pro Thr Asp
C17H26N4O10 (446.16488560000005)
Asp Ser Glu Pro
C17H26N4O10 (446.16488560000005)
Asp Ser Pro Glu
C17H26N4O10 (446.16488560000005)
Asp Thr Asp Pro
C17H26N4O10 (446.16488560000005)
Asp Thr Pro Asp
C17H26N4O10 (446.16488560000005)
Glu Asp Pro Ser
C17H26N4O10 (446.16488560000005)
Glu Asp Ser Pro
C17H26N4O10 (446.16488560000005)
Glu Pro Asp Ser
C17H26N4O10 (446.16488560000005)
Glu Pro Ser Asp
C17H26N4O10 (446.16488560000005)
Glu Ser Asp Pro
C17H26N4O10 (446.16488560000005)
Glu Ser Pro Asp
C17H26N4O10 (446.16488560000005)
His Cys Ser Thr
C16H26N6O7S (446.15836060000004)
His Cys Thr Ser
C16H26N6O7S (446.15836060000004)
His Ser Cys Thr
C16H26N6O7S (446.15836060000004)
His Ser Thr Cys
C16H26N6O7S (446.15836060000004)
His Thr Cys Ser
C16H26N6O7S (446.15836060000004)
His Thr Ser Cys
C16H26N6O7S (446.15836060000004)
Met Cys Pro Pro
Met Pro Cys Pro
Met Pro Pro Cys
Asn Cys Asn Pro
C16H26N6O7S (446.15836060000004)
Asn Cys Pro Asn
C16H26N6O7S (446.15836060000004)
Asn Asn Cys Pro
C16H26N6O7S (446.15836060000004)
Asn Asn Pro Cys
C16H26N6O7S (446.15836060000004)
Asn Pro Cys Asn
C16H26N6O7S (446.15836060000004)
Asn Pro Asn Cys
C16H26N6O7S (446.15836060000004)
Pro Cys Met Pro
Pro Cys Asn Asn
C16H26N6O7S (446.15836060000004)
Pro Cys Pro Met
Pro Asp Asp Thr
C17H26N4O10 (446.16488560000005)
Pro Asp Glu Ser
C17H26N4O10 (446.16488560000005)
Pro Asp Ser Glu
C17H26N4O10 (446.16488560000005)
Pro Asp Thr Asp
C17H26N4O10 (446.16488560000005)
Pro Glu Asp Ser
C17H26N4O10 (446.16488560000005)
Pro Glu Ser Asp
C17H26N4O10 (446.16488560000005)
Pro Met Cys Pro
Pro Met Pro Cys
Pro Asn Cys Asn
C16H26N6O7S (446.15836060000004)
Pro Asn Asn Cys
C16H26N6O7S (446.15836060000004)
Pro Pro Cys Met
Pro Pro Met Cys
Pro Ser Asp Glu
C17H26N4O10 (446.16488560000005)
Pro Ser Glu Asp
C17H26N4O10 (446.16488560000005)
Pro Thr Asp Asp
C17H26N4O10 (446.16488560000005)
Ser Cys His Thr
C16H26N6O7S (446.15836060000004)
Ser Cys Thr His
C16H26N6O7S (446.15836060000004)
Ser Asp Glu Pro
C17H26N4O10 (446.16488560000005)
Ser Asp Pro Glu
C17H26N4O10 (446.16488560000005)
Ser Glu Asp Pro
C17H26N4O10 (446.16488560000005)
Ser Glu Pro Asp
C17H26N4O10 (446.16488560000005)
Ser His Cys Thr
C16H26N6O7S (446.15836060000004)
Ser His Thr Cys
C16H26N6O7S (446.15836060000004)
Ser Pro Asp Glu
C17H26N4O10 (446.16488560000005)
Ser Pro Glu Asp
C17H26N4O10 (446.16488560000005)
Ser Thr Cys His
C16H26N6O7S (446.15836060000004)
Ser Thr His Cys
C16H26N6O7S (446.15836060000004)
Thr Cys His Ser
C16H26N6O7S (446.15836060000004)
Thr Cys Ser His
C16H26N6O7S (446.15836060000004)
Thr Asp Asp Pro
C17H26N4O10 (446.16488560000005)
Thr Asp Pro Asp
C17H26N4O10 (446.16488560000005)
Thr His Cys Ser
C16H26N6O7S (446.15836060000004)
Thr His Ser Cys
C16H26N6O7S (446.15836060000004)
Thr Pro Asp Asp
C17H26N4O10 (446.16488560000005)
Thr Ser Cys His
C16H26N6O7S (446.15836060000004)
Thr Ser His Cys
C16H26N6O7S (446.15836060000004)
Gefitinib
C22H24ClFN4O3 (446.15208759999996)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents
Osmanthuside A
2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropanoic acid 1,1-dimethyl-2-(1-methylethoxy)-2-oxoethyl ester
C24H27ClO6 (446.14960720000005)
ethyl 1-(2,4-difluorophenyl)-6-fluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,8-naphthyridine-3-carboxylate
C22H21F3N4O3 (446.15656720000004)
ethyl 1-(2,4-difluorophenyl)-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxo-1,8-naphthyridine-3-carboxylate
C22H21F3N4O3 (446.15656720000004)
3-ETHYL-5-[(E,2E)-1-PHENYL-4-(1,3,3-TRIMETHYL-1,3-DIHYDRO-2H-INDOL-2-YLIDENE)-2-BUTENYLIDENE]-2-THIOXO-1,3-THIAZOLIDIN-4-ONE
Cvt-6883
GS-6201 (CVT-6883) is a selective adenosine A2B receptor antagonist. GS-6201 displays high affinity and selectivity for the human adenosine A2B receptors (Ki=22 nM)[1]. GS-6201 reduces caspase-1 activity in the heart, and attenuates cardiac remodeling after acute myocardial infarction (AMI) in the mouse[2]. GS-62013 attenuates the airway reactivity induced by NECA, AMP, or allergen in sensitized mice[3].
3-Deschloro-4-Desfluoro-4-Chloro-3-Fluoro Gefitinib
C22H24ClFN4O3 (446.15208759999996)
POLYPHENYL ETHER (5 RINGS) OS-124, STAT. PHASE FOR GC
(2S)-2-[[4-[[(6S)-2,4-dioxo-5,6,7,8-tetrahydro-1H-pteridin-6-yl]methylamino]benzoyl]amino]pentanedioic acid
4-[2-Nitro-5-[4-(phenylmethyl)sulfonyl-1-piperazinyl]phenyl]morpholine
C21H26N4O5S (446.16238260000006)
[(1S,2aR,8bR)-1-(hydroxymethyl)-4-[(3-methoxyphenyl)-oxomethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-(4-fluorophenyl)methanone
[(1R,2aR,8bR)-1-(hydroxymethyl)-4-[(3-methoxyphenyl)-oxomethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-(4-fluorophenyl)methanone
(2R)-2-[(4S,5S)-8-[2-(2-fluorophenyl)ethynyl]-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C23H27FN2O4S (446.16754740000005)
(2S)-2-[(4R,5R)-8-[2-(2-fluorophenyl)ethynyl]-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C23H27FN2O4S (446.16754740000005)
2-[(1S,3S,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
C22H26N2O6S (446.15114960000005)
2-[(1S,3R,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
C22H26N2O6S (446.15114960000005)
2-[(1S,3S,4aR,9aS)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
C22H26N2O6S (446.15114960000005)
[(1R,2aS,8bS)-1-(hydroxymethyl)-4-[(3-methoxyphenyl)-oxomethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-(4-fluorophenyl)methanone
[(1S,2aS,8bS)-1-(hydroxymethyl)-4-[(3-methoxyphenyl)-oxomethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-(4-fluorophenyl)methanone
(2R)-2-[(4R,5R)-8-[2-(2-fluorophenyl)ethynyl]-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C23H27FN2O4S (446.16754740000005)
(2S)-2-[(4S,5S)-8-[2-(2-fluorophenyl)ethynyl]-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C23H27FN2O4S (446.16754740000005)
2-[(1R,3R,4aR,9aS)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
C22H26N2O6S (446.15114960000005)
2-[(1R,3S,4aR,9aS)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
C22H26N2O6S (446.15114960000005)
2-[(1R,3R,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
C22H26N2O6S (446.15114960000005)
2-[(1R,3S,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
C22H26N2O6S (446.15114960000005)
2-[(1S,3R,4aR,9aS)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
C22H26N2O6S (446.15114960000005)